Literature DB >> 11812165

Altered excitation-contraction coupling in myocytes from remodeled myocardium after chronic myocardial infarction.

Young-Kwon Kim1, Song-Jung Kim, Christopher M Kramer, Atsuko Yatani, Gen Takagi, Sunil Mankad, Gyula P Szigeti, Deepak Singh, Sanford P Bishop, Richard P Shannon, Dorothy E Vatner, Stephen F Vatner.   

Abstract

Following myocardial infarction (MI), the left ventricle undergoes progressive dilatation and eccentric hypertrophy, i.e., remodeling, which is greater in the adjacent than the remote region. The cellular mechanisms underlying these regional differences were studied. One (n=5) and 8 weeks (n=8) after anteroapical MI in sheep, cardiac myocytes were isolated from the adjacent and remote regions. At 8 weeks after MI, myocyte function in the remote region was not different from values either in sham controls (n=3) or animals 1 week after MI. At 8 weeks after MI, myocyte contractile function (% contraction) was decreased, P<0.01, in the adjacent region (6.4+/-0.4%), as compared with the remote region (8.8+/-0.5%) and was associated with decreased amplitude of Ca(2+)transients (adjacent, 0.69+/-0.09 v remote, 1.08+/-0.20, P<0.05) and L-type Ca(2+)current density (adjacent, 3.6+/-0.2 v remote, 4.8+/-0.2 pA/pF, P<0.05). Relaxation was also impaired significantly in myocytes from the adjacent region, associated with decreased protein levels of SERCA2a. The myocytes were hypertrophied more in the adjacent region than the remote region. Furthermore, focal areas of central myofibrillar lysis and increased glycogen deposition were observed in the adjacent region. These results indicate that impaired excitation-contraction coupling underlies dysfunction of myocytes from the adjacent non-infarcted myocardium after chronic MI, even in the absence of heart failure. Hypertrophy is implicated as the mechanism, since these changes were noted at 8 weeks, but not at 1 week after MI. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11812165     DOI: 10.1006/jmcc.2001.1490

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  15 in total

1.  Cytochrome c oxidase III as a mechanism for apoptosis in heart failure following myocardial infarction.

Authors:  Changgong Wu; Lin Yan; Christophe Depre; Sunil K Dhar; You-Tang Shen; Junichi Sadoshima; Stephen F Vatner; Dorothy E Vatner
Journal:  Am J Physiol Cell Physiol       Date:  2009-07-22       Impact factor: 4.249

2.  Myofilament dysfunction contributes to impaired myocardial contraction in the infarct border zone.

Authors:  Rafael Shimkunas; Om Makwana; Kimberly Spaulding; Mona Bazargan; Michael Khazalpour; Kiyoaki Takaba; Mehrdad Soleimani; Bat-Erdene Myagmar; David H Lovett; Paul C Simpson; Mark B Ratcliffe; Anthony J Baker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

3.  Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.

Authors:  Aaron S Blom; James J Pilla; Robert C Gorman; Joseph H Gorman; Rupak Mukherjee; Francis G Spinale; Michael A Acker
Journal:  Heart Fail Rev       Date:  2005-06       Impact factor: 4.214

4.  Myocardial injection of a thermoresponsive hydrogel with reactive oxygen species scavenger properties improves border zone contractility.

Authors:  Kimberly A Spaulding; Yang Zhu; Kiyoaki Takaba; Anusuya Ramasubramanian; Anusha Badathala; Henrik Haraldsson; Alexander Collins; Esteban Aguayo; Curran Shah; Arthur W Wallace; Nicholas P Ziats; David H Lovett; Anthony J Baker; Kevin E Healy; Mark B Ratcliffe
Journal:  J Biomed Mater Res A       Date:  2020-05-27       Impact factor: 4.396

5.  Complex electrophysiological remodeling in postinfarction ischemic heart failure.

Authors:  Bence Hegyi; Julie Bossuyt; Leigh G Griffiths; Rafael Shimkunas; Zana Coulibaly; Zhong Jian; Kristin N Grimsrud; Claus S Sondergaard; Kenneth S Ginsburg; Nipavan Chiamvimonvat; Luiz Belardinelli; András Varró; Julius G Papp; Piero Pollesello; Jouko Levijoki; Leighton T Izu; W Douglas Boyd; Tamás Bányász; Donald M Bers; Ye Chen-Izu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

6.  Regulation of the ankyrin-B-based targeting pathway following myocardial infarction.

Authors:  Thomas J Hund; Patrick J Wright; Wen Dun; Jedidiah S Snyder; Penelope A Boyden; Peter J Mohler
Journal:  Cardiovasc Res       Date:  2008-12-14       Impact factor: 10.787

7.  Changes in β-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.

Authors:  Rajat Sethi; Qiming Shao; Bin Ren; Harjot K Saini; Nobuakira Takeda; Naranjan S Dhalla
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

8.  Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway.

Authors:  Song-Jung Kim; Maha Abdellatif; Sharat Koul; George J Crystal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

9.  Left ventricular myocardial contractility is depressed in the borderzone after posterolateral myocardial infarction.

Authors:  Rafael Shimkunas; Zhihong Zhang; Jonathan F Wenk; Mehrdad Soleimani; Michael Khazalpour; Gabriel Acevedo-Bolton; Guanying Wang; David Saloner; Rakesh Mishra; Arthur W Wallace; Liang Ge; Anthony J Baker; Julius M Guccione; Mark B Ratcliffe
Journal:  Ann Thorac Surg       Date:  2013-03-21       Impact factor: 4.330

10.  Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death.

Authors:  Andriy E Belevych; Dmitry Terentyev; Serge Viatchenko-Karpinski; Radmila Terentyeva; Arun Sridhar; Yoshinori Nishijima; Lance D Wilson; Arturo J Cardounel; Kenneth R Laurita; Cynthia A Carnes; George E Billman; Sandor Gyorke
Journal:  Cardiovasc Res       Date:  2009-07-17       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.